Media Summary: Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ... Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ Friedreich's Ataxia (FA) Modeling Project: Actional data resource of efficient data curation across data sources and looking ahead ...

2022 Rdca Dap Workshop Opening - Detailed Analysis & Overview

Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ... Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ Friedreich's Ataxia (FA) Modeling Project: Actional data resource of efficient data curation across data sources and looking ahead ... Panelists: Theresa Mullin (FDA/CDER), Michelle Campbell (FDA/CDER), Billy Dunn (FDA/CDER), Pamela Gavin (NORD), ... Rare Disease (RD) Consortia - Transplant Therapeutics Consortium (TTC): Presentation on how Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ...

Together, NORD and the Critical Path Institute have created a three-part video series entitled, “Accelerating Rare Disease Drug ... Subscribe to C-Path Now ▻▻ FOLLOW C-PATH: LinkedIn: ...

Photo Gallery

2022 RDCA-DAP Workshop: Opening Remarks
2022 RDCA-DAP Workshop:  Future of RDCA-DAP and the Patient Voice
2020 RDCA-DAP Workshop Opening Remarks, Theresa Mullin, FDA, CDER
2022 RDCA-DAP Workshop: New collaborations for RDCA-DAP
2021 RDCA-DAP Annual Workshop: Opening Remarks
2022 RDCA-DAP Workshop: Keynote
2022 RDCA-DAP Workshop: Case Study 4: Friedreich’s Ataxia (FA) Modeling Project
2022 RDCA-DAP Workshop: Impact of RDCA-DAP Panel Discussion
2022 RDCA-DAP Workshop: Case Study 1, Transplant Therapeutics Consortium (TTC)
2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A
Sharing Data With RDCA-DAP: Your Questions Answered
RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases
View Detailed Profile
2022 RDCA-DAP Workshop: Opening Remarks

2022 RDCA-DAP Workshop: Opening Remarks

Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ...

2022 RDCA-DAP Workshop:  Future of RDCA-DAP and the Patient Voice

2022 RDCA-DAP Workshop: Future of RDCA-DAP and the Patient Voice

Presentation(s)/Discussion on

2020 RDCA-DAP Workshop Opening Remarks, Theresa Mullin, FDA, CDER

2020 RDCA-DAP Workshop Opening Remarks, Theresa Mullin, FDA, CDER

2020

2022 RDCA-DAP Workshop: New collaborations for RDCA-DAP

2022 RDCA-DAP Workshop: New collaborations for RDCA-DAP

New collaborations for

2021 RDCA-DAP Annual Workshop: Opening Remarks

2021 RDCA-DAP Annual Workshop: Opening Remarks

Opening

2022 RDCA-DAP Workshop: Keynote

2022 RDCA-DAP Workshop: Keynote

Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ https://www.youtube.com/c/CriticalPathInstitute ...

2022 RDCA-DAP Workshop: Case Study 4: Friedreich’s Ataxia (FA) Modeling Project

2022 RDCA-DAP Workshop: Case Study 4: Friedreich’s Ataxia (FA) Modeling Project

Friedreich's Ataxia (FA) Modeling Project: Actional data resource of efficient data curation across data sources and looking ahead ...

2022 RDCA-DAP Workshop: Impact of RDCA-DAP Panel Discussion

2022 RDCA-DAP Workshop: Impact of RDCA-DAP Panel Discussion

Panelists: Theresa Mullin (FDA/CDER), Michelle Campbell (FDA/CDER), Billy Dunn (FDA/CDER), Pamela Gavin (NORD), ...

2022 RDCA-DAP Workshop: Case Study 1, Transplant Therapeutics Consortium (TTC)

2022 RDCA-DAP Workshop: Case Study 1, Transplant Therapeutics Consortium (TTC)

Rare Disease (RD) Consortia - Transplant Therapeutics Consortium (TTC): Presentation on how

2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A

2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A

Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ...

Sharing Data With RDCA-DAP: Your Questions Answered

Sharing Data With RDCA-DAP: Your Questions Answered

Learn more: https://rarediseases.org/

RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases

RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases

Together, NORD and the Critical Path Institute have created a three-part video series entitled, “Accelerating Rare Disease Drug ...

RDCA-DAP Platform Preview

RDCA-DAP Platform Preview

Subscribe to C-Path Now ▻▻ https://www.youtube.com/c/CriticalPathInstitute FOLLOW C-PATH: LinkedIn: ...